middle.news
Control Bionics Launches $2.06M Rights Issue to Accelerate NeuroStrip Rollout
2:17am on Saturday 30th of August, 2025 AEST
•
Medical Devices
Read Story
Control Bionics Launches $2.06M Rights Issue to Accelerate NeuroStrip Rollout
2:17am on Saturday 30th of August, 2025 AEST
Key Points
Pro rata non-renounceable rights issue to raise $2.06 million at 3.5 cents per share
Offer underwritten to about $1.15 million by major shareholders and partners
Funds to support NeuroStrip commercial rollout and expand NeuroNode capacity
Ongoing clinical trials and marketing initiatives in Australia and the US
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Control Bionics (ASX:CBL)
OPEN ARTICLE